Related Experiment Video
Updated: Jun 16, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Effectiveness of Intensity Modulate Proton Therapy in Managing Complex Multiple Meningiomas: A Dosimetric and
1Department of Medical Physics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.
Intensity-modulated proton therapy (IMPT) offers robust target coverage for multiple meningiomas while significantly reducing dose to organs at risk compared to helical tomotherapy. This proton therapy approach may lower risks for re-irradiation and secondary cancers.
Area of Science:
- Radiation Oncology
- Medical Physics
- Neurosurgery
Background:
- Multiple meningiomas (MM) present challenges in radiation therapy, particularly in sparing nearby neurological organs at risk (OARs).
- Accurate dose delivery and OAR protection are critical for optimizing treatment outcomes and minimizing toxicity.
Purpose of the Study:
- To introduce and evaluate a novel, robust intensity-modulated proton therapy (IMPT) plan for MM.
- To compare the dosimetric and radiobiological outcomes of IMPT against helical tomotherapy (HT) for MM treatment.
Main Methods:
- Developed competing IMPT and HT plans using CT and MRI data from 24 MM patients.
- IMPT utilized a spot-assignment strategy with five static fields, robustly optimized for CTV-sum (considering setup and range uncertainties).
- Helical tomotherapy (HT) was optimized on PTV-sum, with a median prescribed dose of 50.2 GyRBE in 28 fractions.
Main Results:
- IMPT achieved clinically acceptable target coverage (D95% difference of -0.58 ± 0.57 GyRBE).
- IMPT significantly reduced maximal dose (Dmax) and mean dose (Dmean) to most OARs (p < 0.05).
- IMPT lowered integral dose to normal brain tissue by a factor of 1.37-6.97 and reduced NTCP for critical OARs (p < 0.05).
Conclusions:
- Robust target coverage is maintained with IMPT for MM treatment.
- IMPT significantly lowers OAR doses and associated normal tissue complication probabilities (NTCP) compared to HT.
- Reduced integral dose with IMPT may offer benefits for re-irradiation and decrease the risk of secondary malignancies.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017